In addition to viral infection, TMPRSS2 is a potential target for cancer therapy [46] with well-documented links to prostate cancer metastasis, where a TMPRSS2–ERG fusion gene is found in 50% of prostate tumours [47]. Here, TMPRSS2 is linked to prostate neoplasm.